SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling
Metrics: PDF 941 views | HTML 1177 views | ?
Yiyu Qin1,2,3,4,*, Li Meng2,*, Yang Fu5, Zhiwei Quan3, Mingzhe Ma3, Mingzhe Weng3, Zhengdong Zhang4, Cuixiang Gao2, Xinghua Shi2, Koulan Han1
1Clinical College, Yancheng Institute of Health Sciences, Yancheng, Jiangsu 224000, China
2Research Centre of Biomedical Technology, Yancheng Institute of Health Sciences, Yancheng, Jiangsu 224000, China
3Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
4Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China
5Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
*These authors have contributed equally to this work
Yiyu Qin, email: firstname.lastname@example.org
Zhengdong Zhang, email: email@example.com
Koulan Han, email: firstname.lastname@example.org
Keywords: gallbladder cancer, SNORA74B, PHLPP, snoRNA, AKT
Received: October 04, 2016 Accepted: January 08, 2017 Published: February 13, 2017
Small nucleolar RNAs (snoRNAs) have been implicated in the development of many cancers. We therefore examined the differential expression of snoRNAs between gallbladder cancer (GBC) tissues and matched adjacent non-tumor tissues using expression microarray analysis with confirmation by quantitative real-time PCR (qRT-PCR). Western blot analysis showed that SNORA74B levels were higher in GBC than non-tumor tissues. SNORA74B expression was positively associated with local invasion, advanced TNM stage, CA19-9 level, and Ki67 expression in patients with GBC, while it was negatively associated with expression of PHLPP, an endogenous Akt inhibitor. Moreover, SNORA74B expression was prognostic for overall survival (OS) and disease-free survival (DFS). Functional studies revealed that silencing SNORA74B in GBC cells using sh-SNORA74B suppressed cell proliferation, induced G1 arrest, and promoted apoptosis. Preliminary molecular investigation revealed that SNORA74B silencing inhibited activation of the AKT/mTOR signaling pathway, while increasing PHLPP expression. PHLPP depletion using shRNA abrogated sh-SNORA74B suppression of GBC cell proliferation, indicating that the antitumor effects of SNORA74B silencing were mediated by PHLPP. These findings define the important role of SNORA74B in cell proliferation, cell cycle, and apoptosis of GBC, and suggest that it may serve as a novel target for GBC treatment.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.